Cargando…
IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491934/ https://www.ncbi.nlm.nih.gov/pubmed/34628129 http://dx.doi.org/10.1016/j.cyto.2021.155730 |
| _version_ | 1784578831378546688 |
|---|---|
| author | Kow, Chia Siang Zaihan, Abdullah Faiz Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Zaihan, Abdullah Faiz Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8491934 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84919342021-10-06 IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? Kow, Chia Siang Zaihan, Abdullah Faiz Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Cytokine Cytokine Stimulus Elsevier Ltd. 2022-01 2021-10-05 /pmc/articles/PMC8491934/ /pubmed/34628129 http://dx.doi.org/10.1016/j.cyto.2021.155730 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Cytokine Stimulus Kow, Chia Siang Zaihan, Abdullah Faiz Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? |
| title | IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? |
| title_full | IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? |
| title_fullStr | IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? |
| title_full_unstemmed | IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? |
| title_short | IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? |
| title_sort | il-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with covid-19? |
| topic | Cytokine Stimulus |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491934/ https://www.ncbi.nlm.nih.gov/pubmed/34628129 http://dx.doi.org/10.1016/j.cyto.2021.155730 |
| work_keys_str_mv | AT kowchiasiang il6antagoniststoreplacesystemiccorticosteroidsasthepreferredantiinflammatorytherapyinpatientswithcovid19 AT zaihanabdullahfaiz il6antagoniststoreplacesystemiccorticosteroidsasthepreferredantiinflammatorytherapyinpatientswithcovid19 AT ramachandramdineshsangarran il6antagoniststoreplacesystemiccorticosteroidsasthepreferredantiinflammatorytherapyinpatientswithcovid19 AT hasansyedshahzad il6antagoniststoreplacesystemiccorticosteroidsasthepreferredantiinflammatorytherapyinpatientswithcovid19 |